News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

8,942 stories indexed, page 97 of 150

🌍Mar 7, 2023Industryperspective.com

Featured signal

Perspective Group 2H22 Highlights — Perspective Group

Publisher

Perspective Therapeutics

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Perspective TherapeuticsOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🌍Feb 25, 2023Mediaphillipsmedisize.com

Optimize Medical Device Design with Magnesium Thixomolding

Phillips MedisizeOriginal source

🌍Feb 24, 2023Deviceschembio.com

Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

Chembio Diagnostics, Inc.Original source

🇺🇸Feb 24, 2023Industrydyne-tx.com

Rare Disease Day 2023 - Dyne Therapeutics

Dyne TherapeuticsOriginal source

🇺🇸Feb 14, 2023Researchforesitecapital.com

On-Site with Foresite: Meet Michael Rome

Foresite CapitalOriginal source

🌍Feb 9, 2023Mediaphillipsmedisize.com

Metal Injection Molding Makes a Big Impact on Small Parts

Phillips MedisizeOriginal source

🇨🇦Jan 24, 2023Researchucalgary.ca

Student group champions accessibility pilot project in lecture halls

University of CalgaryOriginal source

🇬🇧Jan 4, 2023Industrygenialcompliance.com

First online iPassport User Group a great success - Genial

Genial Genetics (Pathozoom AI)Original source

🌍Dec 29, 2022Industryperspective.com

Perspective shares BOD Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source

🇧🇪Dec 22, 2022Regulatoryfamhp.be

FAMHP reminds of need for customer declaration for buyers of category 1 or 2 chemicals

FAMHP (Belgium)Original source

🌍Dec 15, 2022Industryblueprintgenetics.com

Our service hours during the holiday season

Blueprint Genetics (Quest Diagnostics)Original source

🌍Dec 15, 2022Industrycytomx.com

Results of a phase 2 study of praluzatamab ravtansine (CX-2009) in patients with advanced breast cancer (ABC)

CytomX TherapeuticsOriginal source

🇺🇸Dec 13, 2022Industrydyne-tx.com

FORCE-for-Good-Service-Day-2022 - Dyne Therapeutics

Dyne TherapeuticsOriginal source

🇺🇸Dec 13, 2022CDMOveranex.com

Veranex Acquires Fusion Biotec to Continue Accelerating MedTech Diagnostic Solutions

VeranexOriginal source

🌍Dec 9, 2022Industryperspective.com

Perspective shares CEO Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source

🌍Dec 6, 2022Industryonkuretherapeutics.com

OnKure Therapeutics Appoints Robbie Alton, Pharm., as Vice President of Clinical Operations

OnKure TherapeuticsOriginal source

🇺🇸Nov 29, 2022Industrydyne-tx.com

DM1 Story - BillyDean - Dyne Therapeutics

Dyne TherapeuticsOriginal source

🇫🇷Nov 23, 2022Industrypierre-fabre.com

Creation of the Green Impact Index Consortium

Pierre FabreOriginal source

🇺🇸Nov 23, 2022Researchcidrap.umn.edu

Remdesivir, steroids tied to better COVID hospital outcomes

CIDRAPOriginal source

🇺🇸Nov 23, 2022Industrydyne-tx.com

DM1 Story - Joachim - Dyne Therapeutics

Dyne TherapeuticsOriginal source

🇺🇸Nov 23, 2022Industrydyne-tx.com

DM1 Story - Loraine - Dyne Therapeutics

Dyne TherapeuticsOriginal source

🇺🇸Nov 23, 2022Industrydyne-tx.com

DMD Story - Ravi - Dyne Therapeutics

Dyne TherapeuticsOriginal source

🌍Nov 15, 2022Industrycytomx.com

CX-801, Conditionally Activatable Interferon-alpha 2b Improves Tolerability and Exhibits Preferential Activity in Tumors

CytomX TherapeuticsOriginal source

🇺🇸Nov 2, 2022CDMOnoramco.com

Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

NoramcoOriginal source

🌍Oct 27, 2022Industryq32bio.com

Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of ADX-914 for Atopic Dermatitis

Q32 BioOriginal source

🇬🇧Oct 27, 2022Researchhdruk.ac.uk

Tim Ferris, Jenny Harries and Mauricio Barreto confirmed to join HDR UK’s Annual Scientific Conference

Health Data Research UKOriginal source

🌍Sep 20, 2022Industryq32bio.com

Q32 Bio, a Clinical Stage Biotechnology Company Focused on Therapeutics that Restore Immune Homeostasis, Announces CEO Transition

Q32 BioOriginal source

🇺🇸Sep 17, 2022Researchforesitecapital.com

In Memoriam – Stephen Kaldor

Foresite CapitalOriginal source

🇺🇸Sep 15, 2022Industrydyne-tx.com

joachim and tim

Dyne TherapeuticsOriginal source

🇺🇸Sep 14, 2022Industrynurabio.com

Nura Bio reports preclinical data validating a conserved mechanism of inhibition of NAD hydrolases implicated in neurodegeneration in NEURON Nura Bio™

Nura BioOriginal source

🇺🇸Sep 14, 2022Industrynurabio.com

Marc Freeman wins first annual Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative HealingNura Bio™

Nura BioOriginal source

🌍Sep 7, 2022Industrycytomx.com

Tailoring the Selection of Target, Payload, and Tumor Type to Maximize the Therapeutic Index of Conditionally Activated ADCs

CytomX TherapeuticsOriginal source

🇺🇸Sep 7, 2022Industrydyne-tx.com

diana and jordan 2022

Dyne TherapeuticsOriginal source

🌍Sep 7, 2022Deviceschembio.com

Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay

Chembio Diagnostics, Inc.Original source

🇺🇸Sep 6, 2022Industrysirnaomics.com

Sirnaomics to Present at 3rd Annual Jefferies Asia Forum | Sirnaomics

SirnaomicsOriginal source

🇺🇸Aug 31, 2022Industrydyne-tx.com

rdd2022

Dyne TherapeuticsOriginal source

🇺🇸Aug 26, 2022Industrysirnaomics.com

Sirnaomics Advances GalAhead™-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

SirnaomicsOriginal source

🌍Aug 25, 2022Industryomniab.com

Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

OmniAbOriginal source

🇬🇧Aug 25, 2022Industrygenialcompliance.com

Most common risks to accreditation during inspection - Genial

Genial Genetics (Pathozoom AI)Original source

🇺🇸Aug 23, 2022Industrysirnaomics.com

Sirnaomics' 2022 interim results presentation will be held on 31 August 2022 | Sirnaomics

SirnaomicsOriginal source

🇺🇸Aug 19, 2022Industrysirnaomics.com

Sirnaomics becoming a Constituent of Hang Seng Family of Indexes | Sirnaomics

SirnaomicsOriginal source

🌍Aug 15, 2022Industryq32bio.com

Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

Q32 BioOriginal source

🇺🇸Aug 15, 2022Industrysirnaomics.com

Sirnaomics Develops Peptide Docking Vehicle (PDoV™) Designed for an Enhanced GalNAc Delivery Platform for Novel siRNA Therapeutics | Sirnaomics

SirnaomicsOriginal source

🌍Aug 3, 2022Mediaphillipsmedisize.com

Alzheimer’s Disease: Navigating the Challenging Journey to a Cure

Phillips MedisizeOriginal source

🇺🇸Jul 22, 2022Industrydyne-tx.com

world fshd day 2022

Dyne TherapeuticsOriginal source

🇬🇧Jul 19, 2022Industrygenialcompliance.com

Genial's White Paper on Risk - Genial

Genial Genetics (Pathozoom AI)Original source

🌍Jun 23, 2022Industryq32bio.com

Q32 Bio Presents New Preclinical Data at the International Society of Nephrology Frontiers Meeting Demonstrating the Therapeutic Potential of ADX-097

Q32 BioOriginal source

🌍Jun 21, 2022Industryonkuretherapeutics.com

OnKure Therapeutics Appoints Kevin S. Litwiler, Ph.D., as Senior Vice President of DMPK and Clinical Pharmacology

OnKure TherapeuticsOriginal source

🌍Jun 8, 2022Industryq32bio.com

Shelia Violette, Founder and Chief Scientific Officer of Q32 Bio, to Present at the Keystone Symposia “Resolution of Inflammation” Conference

Q32 BioOriginal source

🌍Jun 7, 2022Industryblueprintgenetics.com

New research collaboration helps shorten the path to diagnosis for rare disease patients through analysis of biobank samples

Blueprint Genetics (Quest Diagnostics)Original source

🌍Jun 2, 2022Industryonkuretherapeutics.com

OnKure Therapeutics Announces First Patient Dosed in the Phase 1b/2 Nautilus Trial of OKI-179 in Combination with Binimetinib in Patients with Advanced NRAS-Mutated Melanoma

OnKure TherapeuticsOriginal source

🇺🇸Jun 1, 2022Researchforesitecapital.com

Thoughts on the Affinivax Acquisition

Foresite CapitalOriginal source

🌍May 31, 2022Industrycerbios.swiss

New additional R&D laboratory unit

Cerbios-Pharma SAOriginal source

🌍May 26, 2022Regulatoryapifarma.pt

Comentário em Formação e Educação por Apifarma - Contactos E Localização - Apifarma

APIFARMA PortugalOriginal source

🌍May 25, 2022Industryblueprintgenetics.com

Blueprint Genetics, a quality leader in genetic testing, embraces new EU regulation (IVDR)

Blueprint Genetics (Quest Diagnostics)Original source

🌍May 23, 2022Regulatoryapifarma.pt

Comentário em Áreas de intervenção por Novo Membro – Apifarma - Informar - Portal de Cursos de Formação Profissional

APIFARMA PortugalOriginal source

🇺🇸May 20, 2022Industrysirnaomics.com

Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summit

SirnaomicsOriginal source

🌍Apr 29, 2022Industrycerbios.swiss

Pharma Tech Outlook – Top 10 EU CMO’s 2022 – Cerbios Cover Story (April 2022)

Cerbios-Pharma SAOriginal source

🌍Apr 25, 2022Industrycooperpharma.ma

Actions terrain auprès des pharmaciens et des médecins

Cooper Pharma MoroccoOriginal source

🌍Apr 25, 2022Industrycooperpharma.ma

Produits soutenus par des unités opérationnelles et des réseaux de médecins spécialisées

Cooper Pharma MoroccoOriginal source